10 Biotech Trades for Second Half of 2011

Description:

According to Adam Feuerstein, "The biotech calendar for the second half of 2011 is filled with drug approval decisions and clinical trial outcomes, enough to keep biotech stocks jumping for the remainder of the year." Read more here.

>>Also: 10 Cheap Biotech Stocks That Could Soar

>>Also: 5 Dow Stocks Likely to Rise After Earnings

Most Viewed Portfolios

View All

Articles

Time to Sell These 5 'Toxic' Stocks

11.21.14 | 11:27 AM

BALTIMORE ( Stockpickr) -- Which stocks should I buy? It's the eternal question that most investors spend most of their time wondering. But is it t...

5 Earnings Short-Squeeze Plays

11.20.14 | 09:26 PM

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tra...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter